Joanne Carter Selected Research

Therapeutics

8/2009

A first-in-man phase i and pharmacokinetic study on CHR-2797 (Tosedostat), an inhibitor of M1 aminopeptidases, in patients with advanced solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joanne Carter Research Topics

Disease

1	Graves Disease (Basedow Disease) 01/2019
1	Hyperthyroidism 01/2019
1	Neoplasms (Cancer) 08/2009

Drug/Important Bio-Agent (IBA)

1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2019
1	AntibodiesIBA 01/2019
1	Thyrotropin Receptors (Thyrotropin Receptor)IBA 01/2019
1	AminopeptidasesIBA 08/2009
1	tosedostatIBA 08/2009

Therapy/Procedure

1	Aftercare (After-Treatment) 01/2019
1	Therapeutics 08/2009